Loading organizations...
Loading organizations...
Immuno-oncology biotech developing optimized monoclonal antibodies.
GamaMabs Pharma has raised $20.6M across 2 funding rounds.
GamaMabs Pharma has raised $20.6M in total across 2 funding rounds.
GamaMabs Pharma has raised $20.6M in total across 2 funding rounds.
GamaMabs Pharma's investors include Alto Invest, InnoBio, IRDInov, iXO Private Equity, Philippe Boucheron, Denis Soubeyran.
GamaMabs Pharma has raised $20.6M across 2 funding rounds. Most recently, it raised $16.4M Series B in December 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 16, 2015 | $16.4M Series B | Alto Invest, InnoBio, IRDInov, iXO Private Equity | |
| Sep 30, 2013 | $4.2M Other Equity | Philippe Boucheron | IRDInov, iXO Private Equity, Denis Soubeyran |